Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Outdoor physical activities improve health by reducing blood sugar, increasing good cholesterol, and decreasing obesity in people with metabolic syndrome.

A new method was created to measure metformin in hair, showing potential for monitoring treatment and medical investigations.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Obesity is linked to higher metabolic syndrome and LH/FSH ratios, but no significant differences exist among PCOS phenotypes.

GnRH treatment can reduce breast cancer cell invasion.

Recognizing and treating early signs of insulin resistance can help prevent type 2 diabetes and improve life quality.

Deleting MPZL3 increases skin oil production and reduces body fat.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

The method effectively detects MeT and TP in dried blood spots after cream application.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

Semaglutide does not significantly increase the risk of hair loss.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Irisin and betatrophin levels change differently in PCOS, which may help assess metabolic risks.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Metabolic syndrome is common in African populations, needing urgent prevention and treatment.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Isotretinoin may reduce inflammation by increasing adiponectin and leptin levels.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Adipose tissue changes in obesity can trigger stress in fat cells.

Finasteride may worsen blood sugar control in diabetic patients.